1995 - Fellow of the American Association for the Advancement of Science (AAAS)
Frank Porreca mainly focuses on Pharmacology, Neuropathic pain, Anesthesia, Opioid and Neuroscience. Frank Porreca interconnects Agonist, Receptor, Antagonist and Cannabinoid receptor in the investigation of issues within Pharmacology. His Neuropathic pain research incorporates themes from Nerve injury, Sensory system, Dorsal root ganglion and Allodynia.
His Anesthesia research includes elements of Naltrexone, Headaches, Rostral ventromedial medulla and Nociception. His Opioid research entails a greater understanding of Internal medicine. His work investigates the relationship between Neuroscience and topics such as Hyperalgesia that intersect with problems in Cholecystokinin, Inflammation and Capsaicin.
Frank Porreca mainly investigates Pharmacology, Opioid, Receptor, Internal medicine and Endocrinology. The various areas that Frank Porreca examines in his Pharmacology study include Agonist, Antagonist and Nociception. His research on Opioid often connects related areas such as Hyperalgesia.
The Receptor study combines topics in areas such as Structure–activity relationship and Stereochemistry. Frank Porreca is exploring Neuropathic pain as part of his Neuroscience and Anesthesia and Neuropathic pain studies. His Anesthesia study combines topics in areas such as Calcitonin gene-related peptide and Rostral ventromedial medulla.
His primary areas of study are Pharmacology, Opioid, Neuroscience, Chronic pain and Neuropathic pain. His research in Pharmacology intersects with topics in Agonist, Receptor, Antagonist, Dynorphin and Dynorphin A. His biological study spans a wide range of topics, including Morphine, Central nucleus of the amygdala and Hyperalgesia, Rostral ventromedial medulla.
His study in Hyperalgesia is interdisciplinary in nature, drawing from both Endocrinology, Prolactin, Prolactin receptor and Nociceptor. His studies in Neuroscience integrate themes in fields like μ-opioid receptor and Migraine. Frank Porreca works mostly in the field of Neuropathic pain, limiting it down to topics relating to Nociception and, in certain cases, GABAA receptor.
Frank Porreca mostly deals with Chronic pain, Neuroscience, Neuropathic pain, Anesthesia and Pharmacology. The Chronic pain study combines topics in areas such as Nociception, Analgesic, Brain stimulation reward, Anxiety and Intensive care medicine. His Neuroscience research includes themes of Hyperalgesia and Opioid.
His Neuropathic pain research is multidisciplinary, incorporating elements of Gabapentin, Duloxetine, Threshold of pain and Intrathecal. His Anesthesia study incorporates themes from EGR1, Transcription factor, Gene expression and Calcitonin gene-related peptide. His Pharmacology study frequently draws connections between adjacent fields such as Allodynia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Central modulation of pain
Michael H. Ossipov;Gregory O. Dussor;Frank Porreca.
Journal of Clinical Investigation (2010)
Chronic pain and medullary descending facilitation
Frank Porreca;Michael H Ossipov;G.F Gebhart.
Trends in Neurosciences (2002)
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Claes R Wahlestedt;Peter Salmi;Liam Good;Johanna Kela.
Proceedings of the National Academy of Sciences of the United States of America (2000)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Mohab M. Ibrahim;Frank Porreca;Josephine Lai;Phillip J. Albrecht.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
Mohab M. Ibrahim;Hongfeng Deng;Alexander Zvonok;Debra A. Cockayne.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8.
Josephine Lai;Michael S Gold;Chang Sook Kim;Di Bian.
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
F Porreca;H I Mosberg;R Hurst;V J Hruby.
Journal of Pharmacology and Experimental Therapeutics (1984)
CB2 cannabinoid receptor-mediated peripheral antinociception.
T.Philip Malan;Mohab M. Ibrahim;Hongfeng Deng;Qian Liu.
Unmasking the tonic-aversive state in neuropathic pain.
Tamara King;Louis Vera-Portocarrero;Tannia Gutierrez;Todd W Vanderah.
Nature Neuroscience (2009)
Statistical analysis of drug-drug and site-site interactions with isobolograms.
Ronald J. Tallarida;Frank Porreca;Alan Cowan.
Life Sciences (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: